Journal of PeriAnesthesia Nursing
Volume 22, Issue 5 , Pages 309-321 , October 2007

Central Anticholinergic Syndrome: A Case Report

  • Daniel D. Moos, CRNA, MS

      Affiliations

    • Corresponding Author InformationAddress correspondence to Daniel D. Moos, CRNA, MS, 4615 Avenue F, Kearney, NE 68847

References 

  1. Katsanoulas K, Papaioannou A, Faidakis O, et al. Undiagnosed central anticholinergic syndrome may lead to dangerous complications. Eur J Anaesthesiol. 1999;16:803–809
  2. Ries CR. Physostigmine in 1999: Tolerability, indications and availability. Can J Anaesth. 1999;46:707
  3. Rupreht J, Dworacek B. Central anticholinergic syndrome in anesthetic practice. Acta Anaesthesiol Belg. 1976;27:45–60
  4. Lawson NL, Johnson JO. Clinical Anesthesia. In:  Barash PG,  Cullen BF,  Stoelting RK editor. Autonomic nervous system: Physiology and pharmacology. (ed 4). Philadelphia, PA: Lippincott Williams & Wilkins; 2001;p. 288–299
  5. Brown DV, Heller F, Barkin R. Anticholinergic syndrome after anesthesia: A case report and review. Am J Ther. 2004;11:144–153
  6. Cook B, Spence AA. Post-operative central anticholinergic syndrome. Eur J Anaesthesiol. 1997;14:1–2
  7. Martin B, Howell PR. Physostigmine: Going…going…gone? (Two cases of central anticholinergic syndrome following anesthesia and its treatment with physostigmine). Eur J Anaesthesiol. 1997;14:467–470
  8. Tortline RL. Central anticholinergic syndrome—The forgotten diagnosis?. Anesthesiol Rev. 1993;20:47–50
  9. Guyton AC, Hall JE. Textbook of Medical Physiology. In:  Guyton AC,  Hall JE editor. The autonomic nervous system and the adrenal medulla. (ed 10). Philadelphia: W.B. Saunders Company; 2000;p. 700;707-708
  10. Schneck HJ, Ruphreht J. Central anticholinergic syndrome (CAS) in anesthesia and intensive care. Acta Anaesthesiol Belg. 1989;40:219–228
  11. Sun KO. Central anticholinergic syndrome following reversal of neuromuscular blockade. Anaesth Intensive Care. 1993;21:363–365
  12. Beech M, Hell C, Nightingale P. Central anticholinergic syndrome. Lancet. 1987;9:1;1089
  13. Grum DF, Osborne LR. Central anticholinergic syndrome following glycopyrrolate. Anesthesiology. 1991;74:191–193
  14. Wingard DW, Grum DF. Glycopyrrolate and the central anticholinergic syndrome. Anesthesiology. 1991;75:1125
  15. Torline RL. Extreme hyperpyrexia associated with central anticholinergic syndrome. Anesthesiology. 1992;76:470–471
  16. Elias MA, Abouleish E. Scopolamine patch can be confusing to the patient and anesthesiologist: A case report. Anesthesiology. 1997;86:743–744
  17. Ezri T, Szmuk P, Konichezky S, et al. Central anticholinergic syndrome complicating management of a difficult airway. Can J Anesth. 1996;43:1079
  18. Rupreht J. The central muscarinic transmission during anaesthesia and recovery—The central anticholinergic syndrome. Anaesthesiol Reanim. 1991;16:250–258
  19. Kulka PJ, Toker H, Heim J, et al. Suspected central anticholinergic syndrome in a 6 week old infant. Anesth Analg. 2004;99:1376
  20. Link J, Papadopoulos G, Dopjans D, et al. Distinct central anticholinergic syndrome following general anesthesia. Eur J Anaesthesiol. 1997;14:15–23
  21. Omoigui S. The Anesthesia Drugs Handbook. In: (Ed 2). St Louis, MO: Mosby; 1995;p. 270–272

PII: S1089-9472(07)00158-X

doi: 10.1016/j.jopan.2007.05.006

Journal of PeriAnesthesia Nursing
Volume 22, Issue 5 , Pages 309-321 , October 2007

Article Tools

* Image Usage & Resolution